期刊文献+

LBH589对胃癌细胞增殖的影响及其机制的研究

Study of LBH589 on cell proliferation of stomach cancer BGC-823 cells
下载PDF
导出
摘要 目的探讨组蛋白去乙酰化酶抑制剂LBH589对胃癌细胞系BGC-823增殖的影响。方法体外培养胃癌BGC-823细胞,MTT检测LBH589对BGC-823细胞增殖率的影响;Western Blotting检测内质网应激相关蛋白GRP78,内质网凋亡相关蛋白CHOP、caspase-4表达水平的改变。结果与对照组相比,给予不同浓度LBH589细胞增殖率明显下降;同时LBH589可以引起内质网应激相关蛋白GRP78表达水平的上调,内质网凋亡相关蛋白CHOP、caspase-4表达水平也明显升高。结论组蛋白去乙酰化酶抑制剂LBH589可能通过内质网应激-凋亡通路诱导BGC-823细胞发生凋亡。 Objective To investigate the effect of histone deacetyltransferase inhibitor LBH589 on cell proliferation of stomach cancer BGC-823 cells.Methods MTT assay was employed to examine the growth suppression of the cells.Western Blotting was used to detect the expressions of Grp78,CHOP and Caspase-4.Results MTT assay showed that vary dosages of LBH589 decreased the growth rate of BGC-823 cells.LBH589 could increase the expressions of Grp78,CHOP and Caspase-4.Conclusion Histone deacetyltransferase inhibitor LBH589 could induce the apoptosis of stomach cancer BGC-823 cells through endoplasmic reticulum stress(ER stress)pathway and decrease the proliferation rate.
出处 《吉林医药学院学报》 2011年第6期311-314,共4页 Journal of Jilin Medical University
基金 吉林省科技厅自然科学基金资助项目(201015240) 吉林医药学院科研基金资助项目(2009-10)
关键词 胃癌 内质网应激 组蛋白去乙酰化酶 stomach cancer ER stress histone deacetyltransferase
  • 相关文献

参考文献9

  • 1Bhalla K N.Epigenetic and chromatin modifiers as targetedtherapy of hematologic malignancies. Oncol . 2005
  • 2Shao W,Growney J D,Feng Y,et al.Activity of deacetylaseinhibitor panobinostat (LBH589)in cutaneous T-cell lym-phoma models:Defining molecular mechanisms of resist-ance. International Journal of Cancer . 2010
  • 3Messaoudi S,Peyrat J F,Brion J D,et al.Recent advancesin Hsp90 inhibitors as antitumor agents. Anticancer A-gents Med Chem . 2008
  • 4P Atadja.Development of the pan-DAC inhibitor panobinostat (LBH589): successes and challenges. Cancer Letters . 2009
  • 5N Khan,M Jeffers,S Kumar,C Hackett,F Boldog,N Khramtsov,X Qian,E Mills,SC Berghs,N Carey,PW Finn,LS Collins,A Tumber,JW Ritchie,PB Jensen,HS Lichenstein,M Sehested.Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors. Biochemical Journal . 2008
  • 6Bolden JE,Peart MJ,Johnstone RW.Anticancer activities of histone deacetylase inhibitors. Nature Reviews Drug Discovery . 2006
  • 7N Khan,M Jeffers,S Kumar,C Hackett,F Boldog,N Khramtsov,X Qian,E Mills,SC Berghs,N Carey,PW Finn,LS Collins,A Tumber,JW Ritchie,PB Jensen,HS Lichenstein,M Sehested.Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors. Biochemical Journal . 2008
  • 8Xu WS,Parmigiani RB,Marks PA.Histone deacetylase inhibitors: molecular mechanisms of action. Oncegene . 2007
  • 9George P,Bali P,Annavarapu S,et al.Combination of the histone deacetylase inhibitor LBH589and the hsp90inhibitor17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3. Blood . 2005

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部